Beware of Asthma Drugs Side Effects!

Pharmaceutical companies that produce asthma medication were asked to add the label of the medicine side effects emotional disorders such as anxiety, depression, and suicide.

The call was issued by the U.S. Food and Drug Administration (FDA) after an investigation for 15 months for asthma drugs manufactured by pharmaceutical Merck & Co., AstraZeneca, and Cornerstone Therapeutics. Previously found a number of cases of patients suffering from psychiatric disorders after taking asthma medication.

"Patients and physicians should be more concerned with the potential for neuropsychiatric disorders while taking this drug," wrote the FDA on its website.

Spokesperson for Merck & Co., Pamela Eisele said the warning is actually a side effect is stated in the label production asthma medication, Singulair. But since the existence of these warnings will be put forward his side's danger in labels.

Singulair is a drug with sales Merc production in the United States with the highest sales value reached 3.5 billion U.S. dollars. Meanwhile, AstraZeneca Pharmaceuticals says the danger of mental disorders was written in the product label, but the side effects, called the new form of depression and insomnia.

The FDA says all parties asthma medication side effects should be mentioned in the form of mental disorders such as agitation, aggression, anxiety, abnormal dreams, hallucinations, depression, insomnia, irrational, excessive fatigue, actions and thoughts of suicide, and tremors.

In Indonesia, sold the various classes of asthma medications. Some can be purchased freely, which is salve, and some have a prescription. Asthma medications may be given in the form of drunk, injected, or sprayed or suction (inhalation).

Although there has been no official statement from the Ministry of Health related information from the FDA is, as the patient could not hurt us equip ourselves about the ins and outs of asthma and its treatment.